Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.
CONCLUSION: As the first-line treatment for schizophrenia in China, olanzapine-ODT is cost-effective compared to olanzapine-SOT and olanzapine-SOT is cost-effective compared to aripiprazole-SOT.
PMID: 30732487 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Abilify | China Health | Databases & Libraries | Economics | Health Management | Insurance | Schizophrenia | Study | Zyprexa